PGBD5 promotes site-specific oncogenic mutations in human tumors

Area of Science:

• Genetics
• Cancer Biology
• Molecular Oncology

Background:

• Genomic rearrangements are common in human cancers.
• The role of transposable elements in cancer development is an area of active research.
• Childhood solid tumors, such as rhabdoid tumors, often exhibit complex genomic alterations.

Purpose of the Study:

• To identify the molecular mechanisms underlying genomic rearrangements in childhood solid tumors.
• To investigate the role of the PGBD5 gene in cancer development.
• To determine if PGBD5 acts as an oncogenic driver in solid tumors.

Main Methods:

• Whole-genome DNA sequencing of rhabdoid tumors.
• Identification and characterization of PGBD5-specific signal (PSS) sequences.
• Assessing PGBD5 association with PSS sequences in tumor cells.
• Evaluating the oncogenic potential of PGBD5 through ectopic expression studies in human cells.
• Investigating the requirement of catalytic residues and DNA repair pathways for PGBD5 activity.

Main Results:

• The PGBD5 gene encodes an active DNA transposase expressed in most childhood solid tumors.
• Previously unrecognized genomic rearrangements were identified in rhabdoid tumors, involving PSS sequences at their breakpoints.
• PGBD5 physically associates with PSS sequences and mediates PGBD5-induced DNA rearrangements.
• Ectopic PGBD5 expression in human cells promotes in vivo cell transformation, requiring its catalytic activity and DNA repair.
• These rearrangements recurrently inactivated tumor-suppressor genes.

Conclusions:

• PGBD5 functions as an oncogenic mutator in solid tumors.
• PGBD5-mediated DNA rearrangements at PSS sequences provide a mechanism for tumor development.
• This finding offers a potential therapeutic target for cancers driven by PGBD5 activity.